Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Thor Industries
THO
$4.11B
| $931K | ﹤0.01% |
10,480
-1,498
| -13% | -$118K |
|
3127
Origin Bancorp
OBK
$1.67B
| $930K | ﹤0.01% |
26,031
-10,046
| -28% | -$333K |
|
3128
PUT
Arbutus Biopharma
ABUS
$908M
| $927K | ﹤0.01% |
299,900
+100,000
| +50% | +$332K |
|
3129
Ocular Therapeutix
OCUL
$2.22B
| $927K | ﹤0.01% |
99,844
-32,143
| -24% | -$252K |
|
3130
Tarsus Pharmaceuticals
TARS
$3.07B
| $923K | ﹤0.01% |
22,794
-12,996
| -36% | -$585K |
|
3131
PUT
ADMA Biologics
ADMA
$2.11B
| $921K | ﹤0.01% |
+50,600
| New | +$1.03M |
|
3132
Garrett Motion
GTX
$5.47B
| $920K | ﹤0.01% |
87,547
+74,067
| +549% | +$746K |
|
3133
Gildan
GIL
$10.6B
| $920K | ﹤0.01% |
18,705
-5,116
| -21% | -$235K |
|
3134
BJ's Restaurants
BJRI
$1.48B
| $919K | ﹤0.01% |
20,613
-9,532
| -32% | -$376K |
|
3135
Winnebago Industries
WGO
$915M
| $919K | ﹤0.01% |
31,674
-25,457
| -45% | -$835K |
|
3136
REX American Resources
REX
$1.44B
| $917K | ﹤0.01% |
37,646
-22,306
| -37% | -$470K |
|
3137
Astec Industries
ASTE
$994M
| $915K | ﹤0.01% |
21,944
-16,047
| -42% | -$609K |
|
3138
AST SpaceMobile
ASTS
$21.4B
| $913K | ﹤0.01% |
19,540
-92,388
| -83% | -$2.67M |
|
3139
Perimeter Solutions
PRM
$5.66B
| $907K | ﹤0.01% |
65,157
-47,014
| -42% | -$543K |
|
3140
Apogee Enterprises
APOG
$897M
| $902K | ﹤0.01% |
22,216
-11,310
| -34% | -$467K |
|
|
CHA
3141
Chagee Holdings Ltd
CHA
$1.95B
| $900K | ﹤0.01% |
+34,467
| New | +$1.06M |
|
3142
Dentsply Sirona
XRAY
$2.27B
| $898K | ﹤0.01% |
56,542
-3,497
| -6% | -$52.3K |
|
3143
Middlesex Water
MSEX
$1.1B
| $896K | ﹤0.01% |
16,532
-10,708
| -39% | -$634K |
|
3144
National Presto Industries
NPK
$998M
| $894K | ﹤0.01% |
9,131
-3,338
| -27% | -$292K |
|
3145
Neogen
NEOG
$2.5B
| $893K | ﹤0.01% |
186,902
-121,581
| -39% | -$698K |
|
3146
B2Gold
BTG
$6.7B
| $893K | ﹤0.01% |
247,658
-1,859
| -0.7% | -$6.1K |
|
3147
Scansource
SCSC
$1.06B
| $891K | ﹤0.01% |
21,314
-15,746
| -42% | -$588K |
|
3148
PUT
ON Semiconductor
ON
$31.8B
| $891K | ﹤0.01% |
17,000
| – | – |
|
|
HUT
3149
Hut 8
HUT
$10.2B
| $890K | ﹤0.01% |
47,853
-14,985
| -24% | -$224K |
|
3150
CALL
KE Holdings
BEKE
$19.2B
| $887K | ﹤0.01% |
50,000
| – | – |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.